Concepedia

Publication | Open Access

Phase II Trial of Sorafenib in Metastatic Thyroid Cancer

DOIFull Paper Access

543

Citations

28

References

2009

Year

Richard T. Kloos, Matthew D. Ringel, Michael V. Knopp, Nathan C. Hall, Mark A. King, Robert C. Stevens, Jiachao Liang, Paul E. Wakely, Vasyl Vasko, Motoyasu Saji,
Journal of Clinical Oncology

Abstract

Sorafenib is reasonably well-tolerated therapy with clinical and biologic antitumor activity in metastatic PTC.

References

YearCitations

Page 1